Endovascular Aneurysm Repair Market By Indication (Abdominal Aortic Aneurysm (Aaa), Thoratic Aortic Aneurysm (Taa)), By Site (Infrarenal, Pararenal), By Anatomy (Traditional, Complex), By Product (Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Endovascular Aneurysm Repair Market

Endovascular aneurysm repair (EVAR) is an preferred treatment option for aortic aneurysm, owing to its advantages over open surgery. These advantages include shorter hospital stay, quick recovery time, improved patient outcomes, and no abdominal surgery. Hence, this EVAR procedure is known as standard intervention for abdominal aortic aneurysm (AAA). In this procedure, a stent is placed in aneurysmal area of the aorta to provide permanent alternative channel for blood flow within the patient’s vasculature, thereby preventing aneurysmal sac from blood flow pressure and rupturing.

Although EVAR has significantly reduced operative risks and recovery time as compared to conventional open surgery, it is still possible to make improvements to the EVAR.. This is attributed to the fact that there have been cases of endoleaks post EVAR procedure. However, to meet such challenges, market players have developed next generation advanced technologies. For instance, Endologix Inc. received FDA approval for its percutaneous endograft delivery system and has a  game-changing new generation Nellix technology, the first and only endovascular sealing product beneficial  in preventing all types of endoleaks.

 

The increase in vascular diseases among population such as pulmonary embolism, cardiac disorders, and atherosclerosis, rise the demand for grafts for treatment, which, in turn, drives the growth of the  EVAR market.  . Furthermore, government is taking initiatives to increase awareness related to availability of aneurysm treatment procedures and devices. Inflated cost associated with EVAR treatment procedures and lack of awareness among people are some of the factors expected to hamper the growth of the market

 

The major players such as Terumo Medical Corporation, Koninklijike Philips N.V., and  Medtronic PLC. are adopting the product launch strategy to improve their product portfolio to maintain competition in the market. For instance, in December 2020, Terumo launched the first commercial case of aortic balloon in the U.S. This device assists physicians in the expansion of aorta, using TREO and RELAY stent-grafts in endovascular aortic repair. Such instances are expected to provide lucrative opportunities to the major players for the growth of the market.

The COVID-19 pandemic forced many companies in the global EVAR market to halt business operations for short term to comply with new government regulations, limiting the spread of the disease. This halt in operations directly impacted revenue flow of the global EVAR market. In addition, there was a halt in manufacturing of industrial products, owing to lack of raw materials and manpower in the lockdown period. Furthermore, no new consignments were received by companies that operated in this sector. Hence, halt in industrial activities and lockdowns for several months affected the global EVAR market, experiencing a gradual recovery during the forecast period.

 

The EVAR market is segmented on the basis of indication, products, site, anatomy, and region. Depending on indication, it is divided into AAA and thoracic aortic aneurysm (TAA). According to site, it is bifurcated into infrarenal and pararenal. As per the anatomy, it is categorized into traditional and complex. By product, it is segregated into percutaneous EVAR, fenestrated EVAR, aortic stents & TAA grafts and others. . By indication, the AAA segment occupied dominant share of 77.9% in 2020, and TAA is expected maintain this trend during the forecast period, owing to high occurrences of AAA disease across the globe.

Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to hold the highest market share during the forecast period

Scope of Endovascular Aneurysm Repair Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Abdominal Aortic Aneurysm (Aaa)

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Thoratic Aortic Aneurysm (Taa)

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Infrarenal

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Pararenal

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Traditional

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Complex

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 Percutaneous Evar

7.2.1 Key market trends, growth factors and opportunities

7.2.2 Market size and forecast, by region

7.2.3 Market analysis by country

7.3 Fenestrated Evar

7.3.1 Key market trends, growth factors and opportunities

7.3.2 Market size and forecast, by region

7.3.3 Market analysis by country

7.4 Aortic Stents & Taa Graft

7.4.1 Key market trends, growth factors and opportunities

7.4.2 Market size and forecast, by region

7.4.3 Market analysis by country

7.5 Others

7.5.1 Key market trends, growth factors and opportunities

7.5.2 Market size and forecast, by region

7.5.3 Market analysis by country

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key trends and opportunities

8.2.2 North America Market size and forecast, by Indication

8.2.3 North America Market size and forecast, by Site

8.2.4 North America Market size and forecast, by Anatomy

8.2.5 North America Market size and forecast, by Product

8.2.6 North America Market size and forecast, by country

8.2.6.1 U.S.

8.2.6.1.1 Market size and forecast, by Indication

8.2.6.1.2 Market size and forecast, by Site

8.2.6.1.3 Market size and forecast, by Anatomy

8.2.6.1.4 Market size and forecast, by Product

8.2.6.2 Canada

8.2.6.2.1 Market size and forecast, by Indication

8.2.6.2.2 Market size and forecast, by Site

8.2.6.2.3 Market size and forecast, by Anatomy

8.2.6.2.4 Market size and forecast, by Product

8.2.6.3 Mexico

8.2.6.3.1 Market size and forecast, by Indication

8.2.6.3.2 Market size and forecast, by Site

8.2.6.3.3 Market size and forecast, by Anatomy

8.2.6.3.4 Market size and forecast, by Product

8.3 Europe

8.3.1 Key trends and opportunities

8.3.2 Europe Market size and forecast, by Indication

8.3.3 Europe Market size and forecast, by Site

8.3.4 Europe Market size and forecast, by Anatomy

8.3.5 Europe Market size and forecast, by Product

8.3.6 Europe Market size and forecast, by country

8.3.6.1 Germany

8.3.6.1.1 Market size and forecast, by Indication

8.3.6.1.2 Market size and forecast, by Site

8.3.6.1.3 Market size and forecast, by Anatomy

8.3.6.1.4 Market size and forecast, by Product

8.3.6.2 Italy

8.3.6.2.1 Market size and forecast, by Indication

8.3.6.2.2 Market size and forecast, by Site

8.3.6.2.3 Market size and forecast, by Anatomy

8.3.6.2.4 Market size and forecast, by Product

8.3.6.3 France

8.3.6.3.1 Market size and forecast, by Indication

8.3.6.3.2 Market size and forecast, by Site

8.3.6.3.3 Market size and forecast, by Anatomy

8.3.6.3.4 Market size and forecast, by Product

8.3.6.4 Spain

8.3.6.4.1 Market size and forecast, by Indication

8.3.6.4.2 Market size and forecast, by Site

8.3.6.4.3 Market size and forecast, by Anatomy

8.3.6.4.4 Market size and forecast, by Product

8.3.6.5 Rest of Europe

8.3.6.5.1 Market size and forecast, by Indication

8.3.6.5.2 Market size and forecast, by Site

8.3.6.5.3 Market size and forecast, by Anatomy

8.3.6.5.4 Market size and forecast, by Product

8.4 Asia-Pacific

8.4.1 Key trends and opportunities

8.4.2 Asia-Pacific Market size and forecast, by Indication

8.4.3 Asia-Pacific Market size and forecast, by Site

8.4.4 Asia-Pacific Market size and forecast, by Anatomy

8.4.5 Asia-Pacific Market size and forecast, by Product

8.4.6 Asia-Pacific Market size and forecast, by country

8.4.6.1 China

8.4.6.1.1 Market size and forecast, by Indication

8.4.6.1.2 Market size and forecast, by Site

8.4.6.1.3 Market size and forecast, by Anatomy

8.4.6.1.4 Market size and forecast, by Product

8.4.6.2 Japan

8.4.6.2.1 Market size and forecast, by Indication

8.4.6.2.2 Market size and forecast, by Site

8.4.6.2.3 Market size and forecast, by Anatomy

8.4.6.2.4 Market size and forecast, by Product

8.4.6.3 India

8.4.6.3.1 Market size and forecast, by Indication

8.4.6.3.2 Market size and forecast, by Site

8.4.6.3.3 Market size and forecast, by Anatomy

8.4.6.3.4 Market size and forecast, by Product

8.4.6.4 South Korea

8.4.6.4.1 Market size and forecast, by Indication

8.4.6.4.2 Market size and forecast, by Site

8.4.6.4.3 Market size and forecast, by Anatomy

8.4.6.4.4 Market size and forecast, by Product

8.4.6.5 Rest Of Asia Pacific

8.4.6.5.1 Market size and forecast, by Indication

8.4.6.5.2 Market size and forecast, by Site

8.4.6.5.3 Market size and forecast, by Anatomy

8.4.6.5.4 Market size and forecast, by Product

8.5 LAMEA

8.5.1 Key trends and opportunities

8.5.2 LAMEA Market size and forecast, by Indication

8.5.3 LAMEA Market size and forecast, by Site

8.5.4 LAMEA Market size and forecast, by Anatomy

8.5.5 LAMEA Market size and forecast, by Product

8.5.6 LAMEA Market size and forecast, by country

8.5.6.1 Latin America

8.5.6.1.1 Market size and forecast, by Indication

8.5.6.1.2 Market size and forecast, by Site

8.5.6.1.3 Market size and forecast, by Anatomy

8.5.6.1.4 Market size and forecast, by Product

8.5.6.2 Middle East

8.5.6.2.1 Market size and forecast, by Indication

8.5.6.2.2 Market size and forecast, by Site

8.5.6.2.3 Market size and forecast, by Anatomy

8.5.6.2.4 Market size and forecast, by Product

8.5.6.3 Africa

8.5.6.3.1 Market size and forecast, by Indication

8.5.6.3.2 Market size and forecast, by Site

8.5.6.3.3 Market size and forecast, by Anatomy

8.5.6.3.4 Market size and forecast, by Product

9.1. Introduction

9.2. Top winning strategies

9.3. Product Mapping of Top 10 Player

9.4. Competitive Dashboard

9.5. Competitive Heatmap

9.6. Key developments

10.1 Abbott Laboratories

10.1.1 Company overview

10.1.2 Company snapshot

10.1.3 Operating business segments

10.1.4 Product portfolio

10.1.5 Business performance

10.1.6 Key strategic moves and developments

10.2 Becton, Dickinson and Company

10.2.1 Company overview

10.2.2 Company snapshot

10.2.3 Operating business segments

10.2.4 Product portfolio

10.2.5 Business performance

10.2.6 Key strategic moves and developments

10.3 Cardinal Health Inc

10.3.1 Company overview

10.3.2 Company snapshot

10.3.3 Operating business segments

10.3.4 Product portfolio

10.3.5 Business performance

10.3.6 Key strategic moves and developments

10.4 cook medical

10.4.1 Company overview

10.4.2 Company snapshot

10.4.3 Operating business segments

10.4.4 Product portfolio

10.4.5 Business performance

10.4.6 Key strategic moves and developments

10.5 Endologix Inc

10.5.1 Company overview

10.5.2 Company snapshot

10.5.3 Operating business segments

10.5.4 Product portfolio

10.5.5 Business performance

10.5.6 Key strategic moves and developments

10.6 Lombard Medical Inc

10.6.1 Company overview

10.6.2 Company snapshot

10.6.3 Operating business segments

10.6.4 Product portfolio

10.6.5 Business performance

10.6.6 Key strategic moves and developments

10.7 Medtronic Plc

10.7.1 Company overview

10.7.2 Company snapshot

10.7.3 Operating business segments

10.7.4 Product portfolio

10.7.5 Business performance

10.7.6 Key strategic moves and developments

10.8 Koninklijke Philips N.V.

10.8.1 Company overview

10.8.2 Company snapshot

10.8.3 Operating business segments

10.8.4 Product portfolio

10.8.5 Business performance

10.8.6 Key strategic moves and developments

10.9 Terumo Medical Corporation

10.9.1 Company overview

10.9.2 Company snapshot

10.9.3 Operating business segments

10.9.4 Product portfolio

10.9.5 Business performance

10.9.6 Key strategic moves and developments

10.10 W. L. Gore & Associates Inc

10.10.1 Company overview

10.10.2 Company snapshot

10.10.3 Operating business segments

10.10.4 Product portfolio

10.10.5 Business performance

10.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)

TABLE 2. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY REGION , 2020-2030,($MILLION)

TABLE 3. ENDOVASCULAR ANEURYSM REPAIR MARKET ABDOMINAL AORTIC ANEURYSM (AAA) BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR THORATIC AORTIC ANEURYSM (TAA), BY REGION , 2020-2030,($MILLION)

TABLE 5. ENDOVASCULAR ANEURYSM REPAIR MARKET THORATIC AORTIC ANEURYSM (TAA) BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)

TABLE 7. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR INFRARENAL, BY REGION , 2020-2030,($MILLION)

TABLE 8. ENDOVASCULAR ANEURYSM REPAIR MARKET INFRARENAL BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PARARENAL, BY REGION , 2020-2030,($MILLION)

TABLE 10. ENDOVASCULAR ANEURYSM REPAIR MARKET PARARENAL BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)

TABLE 12. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR TRADITIONAL, BY REGION , 2020-2030,($MILLION)

TABLE 13. ENDOVASCULAR ANEURYSM REPAIR MARKET TRADITIONAL BY COUNTRY, 2020-2030,($MILLION)

TABLE 14. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR COMPLEX, BY REGION , 2020-2030,($MILLION)

TABLE 15. ENDOVASCULAR ANEURYSM REPAIR MARKET COMPLEX BY COUNTRY, 2020-2030,($MILLION)

TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 17. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PERCUTANEOUS EVAR, BY REGION , 2020-2030,($MILLION)

TABLE 18. ENDOVASCULAR ANEURYSM REPAIR MARKET PERCUTANEOUS EVAR BY COUNTRY, 2020-2030,($MILLION)

TABLE 19. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR FENESTRATED EVAR, BY REGION , 2020-2030,($MILLION)

TABLE 20. ENDOVASCULAR ANEURYSM REPAIR MARKET FENESTRATED EVAR BY COUNTRY, 2020-2030,($MILLION)

TABLE 21. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR AORTIC STENTS & TAA GRAFT, BY REGION , 2020-2030,($MILLION)

TABLE 22. ENDOVASCULAR ANEURYSM REPAIR MARKET AORTIC STENTS & TAA GRAFT BY COUNTRY, 2020-2030,($MILLION)

TABLE 23. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 24. ENDOVASCULAR ANEURYSM REPAIR MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 25. ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 26. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)

TABLE 27. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)

TABLE 28. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)

TABLE 29. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 30. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 31. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 32. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 33. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 34. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 35. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 36. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 37. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 38. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 39. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 40. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 41. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 42. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 43. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)

TABLE 44. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)

TABLE 45. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)

TABLE 46. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 47. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 48. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 49. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 50. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 51. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 52. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 53. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 54. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 55. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 56. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 57. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 58. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 59. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 60. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 61. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 62. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 63. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 64. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 65. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 66. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 67. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 68. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)

TABLE 69. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)

TABLE 70. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)

TABLE 71. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 72. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 73. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 74. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 75. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 76. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 77. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 78. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 79. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 80. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 81. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 82. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 83. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 84. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 85. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 86. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 87. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 88. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 89. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 90. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 91. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 92. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 93. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)

TABLE 94. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)

TABLE 95. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)

TABLE 96. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 97. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 98. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 99. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 100. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 101. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 102. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 103. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 104. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 105. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 106. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)

TABLE 107. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)

TABLE 108. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)

TABLE 109. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)

TABLE 110.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 111.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 112.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 113.ABBOTT LABORATORIES: NET SALES,

TABLE 114.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 118.BECTON, DICKINSON AND COMPANY: NET SALES,

TABLE 119.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 120.CARDINAL HEALTH INC: COMPANY SNAPSHOT

TABLE 121.CARDINAL HEALTH INC: OPERATING SEGMENTS

TABLE 122.CARDINAL HEALTH INC: PRODUCT PORTFOLIO

TABLE 123.CARDINAL HEALTH INC: NET SALES,

TABLE 124.CARDINAL HEALTH INC: KEY STRATERGIES

TABLE 125.COOK MEDICAL: COMPANY SNAPSHOT

TABLE 126.COOK MEDICAL: OPERATING SEGMENTS

TABLE 127.COOK MEDICAL: PRODUCT PORTFOLIO

TABLE 128.COOK MEDICAL: NET SALES,

TABLE 129.COOK MEDICAL: KEY STRATERGIES

TABLE 130.ENDOLOGIX INC: COMPANY SNAPSHOT

TABLE 131.ENDOLOGIX INC: OPERATING SEGMENTS

TABLE 132.ENDOLOGIX INC: PRODUCT PORTFOLIO

TABLE 133.ENDOLOGIX INC: NET SALES,

TABLE 134.ENDOLOGIX INC: KEY STRATERGIES

TABLE 135.LOMBARD MEDICAL INC: COMPANY SNAPSHOT

TABLE 136.LOMBARD MEDICAL INC: OPERATING SEGMENTS

TABLE 137.LOMBARD MEDICAL INC: PRODUCT PORTFOLIO

TABLE 138.LOMBARD MEDICAL INC: NET SALES,

TABLE 139.LOMBARD MEDICAL INC: KEY STRATERGIES

TABLE 140.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 141.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 142.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 143.MEDTRONIC PLC: NET SALES,

TABLE 144.MEDTRONIC PLC: KEY STRATERGIES

TABLE 145.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 146.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS

TABLE 147.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 148.KONINKLIJKE PHILIPS N.V.: NET SALES,

TABLE 149.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES

TABLE 150.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT

TABLE 151.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS

TABLE 152.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO

TABLE 153.TERUMO MEDICAL CORPORATION: NET SALES,

TABLE 154.TERUMO MEDICAL CORPORATION: KEY STRATERGIES

TABLE 155.W. L. GORE & ASSOCIATES INC: COMPANY SNAPSHOT

TABLE 156.W. L. GORE & ASSOCIATES INC: OPERATING SEGMENTS

TABLE 157.W. L. GORE & ASSOCIATES INC: PRODUCT PORTFOLIO

TABLE 158.W. L. GORE & ASSOCIATES INC: NET SALES,

TABLE 159.W. L. GORE & ASSOCIATES INC: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.ENDOVASCULAR ANEURYSM REPAIR MARKET SEGMENTATION

FIGURE 2.ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030

FIGURE 3.ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.ENDOVASCULAR ANEURYSM REPAIR MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY INDICATION,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ABDOMINAL AORTIC ANEURYSM (AAA) ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF THORATIC AORTIC ANEURYSM (TAA) ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 14.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY SITE,2020(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF INFRARENAL ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PARARENAL ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 17.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY ANATOMY,2020(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF TRADITIONAL ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF COMPLEX ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 20.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY PRODUCT,2020(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF PERCUTANEOUS EVAR ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF FENESTRATED EVAR ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF AORTIC STENTS & TAA GRAFT ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)

FIGURE 25.ENDOVASCULAR ANEURYSM REPAIR MARKET BY REGION,2020

FIGURE 26.U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 27.CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 28.MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 29.GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 30.ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 31.FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 32.SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 33.REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 34.CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 35.JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 36.INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 37.SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 38.REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 39.LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 40.MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 41.AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)

FIGURE 42. TOP WINNING STRATEGIES, BY YEAR

FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 46.COMPETITIVE DASHBOARD

FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 48.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 49.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)

FIGURE 50.CARDINAL HEALTH INC.: NET SALES ,($MILLION)

FIGURE 51.COOK MEDICAL.: NET SALES ,($MILLION)

FIGURE 52.ENDOLOGIX INC.: NET SALES ,($MILLION)

FIGURE 53.LOMBARD MEDICAL INC.: NET SALES ,($MILLION)

FIGURE 54.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)

FIGURE 56.TERUMO MEDICAL CORPORATION.: NET SALES ,($MILLION)

FIGURE 57.W. L. GORE & ASSOCIATES INC.: NET SALES ,($MILLION